TOP2A is highly expressed in HGSOC tissues and cisplatin-resistant cells, with high levels strongly associated with tumor progression (advanced stage, high grade, lymph node metastasis) and poor prognosis. Here, TOP2A is linked to metastatic malignant neoplasm in the lymph nodes.